trending Market Intelligence /marketintelligence/en/news-insights/trending/k7zfhaTbGCQx5PVmUsmdLg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Elanco receives 2nd information request from US FTC over $7.6B Bayer deal

Elanco Animal Health Inc. received a second information request from the U.S. Federal Trade Commission regarding its $7.6 billion acquisition of Bayer AG's animal health business.

Greenfield, Ind.-based Elanco said the request was part of the standard regulatory review process under the Hart-Scott-Rodino Act. The request essentially extends the waiting period imposed under the antitrust act for 30 days after the companies involved have provided the information sought.

The transaction, which is subject to regulatory approval and closing conditions, is still expected to close in mid-2020, according to Elanco.

Elanco has previously said the deal will double its companion animal business, advance the company's intentional portfolio mix transformation and create a balance between its food animal and companion animal segments.